How were PDL BioPharma's earnings last quarter?

PDL BioPharma, Inc. (NASDAQ:PDLI) posted its quarterly earnings results on Thursday, August, 6th. The biotechnology company reported ($0.43) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.10 by $0.53. The biotechnology company had revenue of $5.21 million for the quarter.

What other stocks do shareholders of PDL BioPharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PDL BioPharma investors own include AT&T (T) , OPKO Health (OPK) , Advanced Micro Devices (AMD) , Novavax (NVAX) , General Electric (GE) , Teva Pharmaceutical Industries (TEVA) , Bank of America (BAC) , Bausch Health Companies (BHC) and Cara Therapeutics (CARA) .

NASDAQ:PDLI

PDL BioPharma (PDLI) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free PDLI Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $2.47
▼
$2.47
50-Day Range: $2.47
▼
$2.47
52-Week Range: $2.09
▼
$3.86

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get PDL BioPharma alerts:

Ad Crypto 101 Media

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

About PDL BioPharma Stock (NASDAQ:PDLI)

PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.

Ad Crypto 101 Media

SHOCKING Crypto Leak…

Claim your free seat by clicking here now.

PDLI Stock News Headlines

February 23, 2024 | morningstar.com

GT Biopharma Inc GTBP

October 24, 2023 | thestreet.com

Health Winners & Losers: Maxygen

April 19, 2024 | Altimetry (Ad)

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

October 18, 2023 | investing.com

PDLI Historical Data

June 28, 2023 | finance.yahoo.com

ABVC - ABVC BioPharma, Inc.

June 23, 2023 | finance.yahoo.com

RDHL - RedHill Biopharma Ltd.

March 12, 2023 | seekingalpha.com

LABP

January 15, 2023 | msn.com

A Persons Deprived of Liberty (PDL) interacts with his pet mouse inside the jail

April 19, 2024 | Altimetry (Ad)

Secret Bull Market Starts in This Unusual Sector

January 4, 2023 | thestreet.com

PDL BioPharma Stock To Go Ex-dividend Monday (PDLI)

December 14, 2022 | thestreet.com

PDL BioPharma Stock To Go Ex-dividend Tomorrow (PDLI)

August 6, 2022 | thestreet.com

Cramer's 'Mad Money' Recap: Politics Is Overrated

May 21, 2022 | forbes.com

Steris (STE)

See More Headlines

Receive PDLI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PDL BioPharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 8/06/2020
Today: 4/19/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Biological products, except diagnostic
Sub-Industry: Biotechnology
Current Symbol: NASDAQ:PDLI
CUSIP: 69329Y10
CIK: 882104
Web: www.pdl.com
Phone: 775-832-8500
Fax: 775-832-8501
Employees: 109
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Optionable
Beta: N/A

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

Mr. Dominique P. Monnet (Age 59)
CEO, Pres & Director
Comp: $1.2M
Mr. Edward A. Imbrogno CPA (Age 55)
VP, CFO & Chief Accounting Officer
Comp: $564.14k
Mr. Christopher L. Stone (Age 56)
VP, Gen. Counsel & Sec.
Comp: $1.15M
Mr. Nathan Kryszak
Deputy Gen. Counsel & Assistant Sec.

Key Competitors

View All Competitors

PDLI Stock Analysis - Frequently Asked Questions

How were PDL BioPharma's earnings last quarter?: PDL BioPharma, Inc. (NASDAQ:PDLI) posted its quarterly earnings results on Thursday, August, 6th. The biotechnology company reported ($0.43) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.10 by $0.53. The biotechnology company had revenue of $5.21 million for the quarter.
What other stocks do shareholders of PDL BioPharma own?: Based on aggregate information from My MarketBeat watchlists, some companies that other PDL BioPharma investors own include AT&T (T), OPKO Health (OPK), Advanced Micro Devices (AMD), Novavax (NVAX), General Electric (GE), Teva Pharmaceutical Industries (TEVA), Bank of America (BAC), Bausch Health Companies (BHC) and Cara Therapeutics (CARA).

This page (NASDAQ:PDLI) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

PDL BioPharma (PDLI) Stock Price, News & Analysis

About PDL BioPharma Stock (NASDAQ:PDLI)

PDLI Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

PDLI Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info